Novartis AG (NOVN.SW) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

novn.sw · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Novartis AG (NOVN.SW) measures how much investors pay for each dollar of the company's trailing earnings. NOVN.SW's current PE ratio of N/A is calculated by dividing its stock price of $117.04 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)

= $117.04 ÷ — = N/A

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

NOVN.SW pe ratio · 6 questions

NOVN.SW's current PE ratio is N/A as of 2026-06-09, based on a stock price of $117.04 and TTM EPS of —. Data sourced from Financial Modeling Prep via NOVN.SW's SEC 10-K and 10-Q filings.

NOVN.SW PE ratioWhat is NOVN.SW PE ratioCurrent PE ratio of NOVN.SWNOVN.SW PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Novartis AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09